Argenx NV ADR (ARGX) had the best quarter in 2017 by a large-cap US stock in Q4 2017, returning 180.7%.
| ASSET | QUARTER | % RETURN |
|---|---|---|
argenx NV ADR (ARGX) | Q4 2017 | 180.75% |
Madrigal Pharmaceuticals (MDGL) | Q3 2017 | 177.14% |
Arrowhead Pharmaceuticals (ARWR) | Q3 2017 | 164.02% |
BeiGene (ONC) | Q3 2017 | 128.84% |
Roku (ROKU) | Q4 2017 | 105.48% |
Madrigal Pharmaceuticals (MDGL) | Q4 2017 | 103.3% |
Wayfair (W) | Q2 2017 | 90.39% |
Leonardo DRS, Inc Common Stock (DRS) | Q3 2017 | 82.36% |
Insmed (INSM) | Q3 2017 | 80.2% |
Sociedad Quimica y Minera de Chile SA ADR B (SQM) | Q3 2017 | 69.5% |
Roku (ROKU) | Q3 2017 | 68.19% |
AXIA Energia (AXIA) | Q3 2017 | 63.16% |
Stellantis (STLA) | Q3 2017 | 62.97% |
Leonardo DRS, Inc Common Stock (DRS) | Q2 2017 | 60.7% |
Nutanix (NTNX) | Q4 2017 | 59.21% |
Summit Therapeutics (SMMT) | Q1 2017 | 57.66% |
Ecopetrol SA ADR (EC) | Q4 2017 | 55.97% |
Alnylam Pharmaceuticals (ALNY) | Q2 2017 | 55.51% |
NRG Energy (NRG) | Q1 2017 | 52.06% |
Molina Healthcare (MOH) | Q2 2017 | 52.04% |
Carvana (CVNA) | Q2 2017 | 51.63% |
Kratos Defense & Security Solutions (KTOS) | Q2 2017 | 50.83% |
NRG Energy (NRG) | Q3 2017 | 47.76% |
Huazhu (HTHT) | Q3 2017 | 47.16% |
Vertex Pharmaceuticals (VRTX) | Q1 2017 | 46.92% |
Large-cap stocks are treated as having a market cap of $10B+.